Lab
Laboratory Corporation of America
Laboratory Corporation of America was paid $98K by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 25% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA
SAN LEANDRO, CA 94577
SAN LEANDRO, CA 94577
33aNPI1861473480assigned 11/10/2005
33bProvider typeClinical Medical Laboratory
28Total paid$98K
24GClaims13,605
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#329 of 561
Median peer was paid$222K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,115 | $16K | |
| 2019 | 2,531 | $25K | |
| 2020 | 1,510 | $8K | |
| 2021 | 1,503 | $7K | |
| 2022 | 1,507 | $8K | |
| 2023 | 2,621 | $17K | |
| 2024incomplete | 2,818 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 25% | 3,823 | 3,518 | $24K |
| 80053 | Comprehensive metabolic panel | 22% | 2,408 | 2,280 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 18% | 393 | 388 | $18K |
| 85610 | 13% | 3,933 | 3,134 | $12K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.8% | 121 | 119 | $7K |
| 86003 | 6.8% | 57 | 57 | $7K | |
| 85730 | 2.6% | 484 | 477 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.8% | 58 | 58 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.3% | 82 | 82 | $1K |
| 99199 | Unlisted special service, procedure or report | <1% | 113 | 103 | $898.73 |
| 85652 | <1% | 172 | 168 | $410.40 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 50 | 47 | $363.50 |
46 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $307.08 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $304.32 |
| 80061 | Lipid panel | <1% | 38 | $172.40 |
| 84702 | <1% | 14 | $172.12 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $163.66 |
| 84156 | <1% | 53 | $154.51 | |
| 82785 | <1% | 13 | $150.28 | |
| 85027 | <1% | 25 | $137.04 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 27 | $107.34 |
| 83690 | <1% | 13 | $79.04 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $58.08 |
| 86592 | <1% | 18 | $57.24 | |
| 81001 | <1% | 12 | $26.40 | |
| 80050 | General health panel | <1% | 17 | $23.57 |
| 36415 | Collection of venous blood by venipuncture | <1% | 246 | $19.74 |
| 84439 | <1% | 14 | $16.02 | |
| 80355 | 0% | 35 | $0.00 | |
| 80354 | 0% | 36 | $0.00 | |
| 80348 | 0% | 36 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 488 | $0.00 |
| 80326 | 0% | 22 | $0.00 | |
| 80373 | 0% | 38 | $0.00 | |
| 80366 | 0% | 35 | $0.00 | |
| 80372 | 0% | 35 | $0.00 | |
| 80365 | 0% | 26 | $0.00 | |
| 80361 | 0% | 39 | $0.00 | |
| 80344 | 0% | 22 | $0.00 | |
| 80360 | 0% | 34 | $0.00 | |
| 80338 | 0% | 35 | $0.00 | |
| 80347 | 0% | 23 | $0.00 | |
| 83992 | 0% | 35 | $0.00 | |
| 80331 | 0% | 22 | $0.00 | |
| 80364 | 0% | 22 | $0.00 | |
| 80334 | 0% | 22 | $0.00 | |
| 80370 | 0% | 22 | $0.00 | |
| 80377 | 0% | 22 | $0.00 | |
| 80337 | 0% | 22 | $0.00 | |
| 80341 | 0% | 22 | $0.00 | |
| 80358 | 0% | 36 | $0.00 | |
| 80357 | 0% | 22 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 71 | $0.00 |
| 80371 | 0% | 34 | $0.00 | |
| 80368 | 0% | 35 | $0.00 | |
| 80367 | 0% | 22 | $0.00 | |
| 80353 | 0% | 35 | $0.00 | |
| 80359 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VP)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.